Wells Fargo Maintains Overweight on Hologic, Raises Price Target to $95

Wells Fargo analyst Dan Leonard maintains Hologic (NASDAQ:HOLX) with a Overweight and raises the price target from $90 to $95.Wells Fargo analyst Dan Leonard maintains Hologic (NASDAQ:HOLX) with a Overweight and raises the price target from $90 to $95.